Minimization of genetic distances by the consensus, ancestral, and center-of-tree (COT) sequences for HIV-1 variants within an infected individual and the design of reagents to test immune reactivity

Virology

Volumn 348, Issue 2, 2006, Pages 437-448

  Kesturu, Girish S ^a   Colleton, Bonnie A ^c   Liu, Yi ^b   Heath, Laura ^b   Shaikh, Obaid Shakil ^a   Rinaldo Jr , Charles R ^c   Shankarappa, Raj ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibodies; Cytotoxic T lymphocytes; Genetic variation; HCV; HIV 1; Immune response; Immunotherapy; Quasispecies; Vaccine

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CONSENSUS SEQUENCE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENVELOPE GENE; GENETIC ANALYSIS; GENETIC DISTANCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CONSENSUS SEQUENCE; DNA, VIRAL; EVOLUTION, MOLECULAR; GENES, ENV; HIV INFECTIONS; HIV-1; HUMANS; INDICATORS AND REAGENTS; MALE; PHYLOGENY; T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS);

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33646491865     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.11.055     Document Type: Article

References (61)

1. Addo M.M., Yu X.G., Rathod A., Cohen D., Eldridge R.L., Strick D., Johnston M.N., Corcoran C., Wurcel A.G., Fitzpatrick C.A., Feeney M.E., Rodriguez W.R., Basgoz N., Draenert R., Stone D.R., Brander C., Goulder P.J., Rosenberg E.S., Altfeld M., and Walker B.D. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77 3 (2003) 2081-2092
2. Allen T.M., O'Connor D.H., Jing P., Dzuris J.L., Mothe B.R., Vogel T.U., Dunphy E., Liebl M.E., Emerson C., Wilson N., Kunstman K.J., Wang X., Allison D.B., Hughes A.L., Desrosiers R.C., Altman J.D., Wolinsky S.M., Sette A., and Watkins D.I. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407 (2000) 386-390
3. Allen T.M., Altfeld M., Geer S.C., Kalife E.T., Moore C., O'Sullivan K.M., Desouza I., Feeney M.E., Eldridge R.L., Maier E.L., Kaufmann D.E., Lahaie M.P., Reyor L., Tanzi G., Johnston M.N., Brander C., Draenert R., Rockstroh J.K., Jessen H., Rosenberg E.S., Mallal S.A., and Walker B.D. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79 21 (2005) 13239-13249
4. Altfeld M., Addo M.M., Shankarappa R., Lee P.K., Allen T.M., Yu X.G., Rathod A., Harlow J., O'Sullivan K., Johnston M.N., Goulder P.J., Mullins J.I., Rosenberg E.S., Brander C., Korber B., and Walker B.D. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J. Virol. 77 13 (2003) 7330-7340
5. Anderson J.P., Rodrigo A.G., Learn G.H., Wang Y., Weinstock H., Kalish M.L., Robbins K.E., Hood L., and Mullins J.I. Substitution model of sequence evolution for the human immunodeficiency virus type 1 subtype B gp120 gene over the C2-V5 region. J. Mol. Evol. 53 1 (2001) 55-62
6. Cornelissen M., Mulder-Kampinga G., Veenstra J., Zorgdrager F., Kuiken C., Hartman S., Dekker J., van der Hoek L., Sol C., Coutinho R., and Goudsmit J. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69 (1995) 1810-1818
7. Doria-Rose N.A., Learn G.H., Rodrigo A.G., Nickle D.C., Li F., Mahalanabis M., Hensel M.T., McLaughlin S., Edmonson P.F., Montefiori D., Barnett S.W., Haigwood N.L., and Mullins J.I. Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope. J. Virol. 79 17 (2005) 11214-11224
8. Eigen M. Viral quasispecies. Sci. Am. 269 1 (1993) 42-49
9. Frahm N., Korber B.T., Adams C.M., Szinger J.J., Draenert R., Addo M.M., Feeney M.E., Yusim K., Sango K., Brown N.V., SenGupta D., Piechocka-Trocha A., Simonis T., Marincola F.M., Wurcel A.G., Stone D.R., Russell C.J., Adolf P., Cohen D., Roach T., StJohn A., Khatri A., Davis K., Mullins J., Goulder P.J., Walker B.D., and Brander C. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 78 5 (2004) 2187-2200
10. Gao F., Bhattacharya T., Gaschen B., Taylor J., Moore J.P., Novitsky V., Yusim K., Lang D., Foley B., Beddows S., Alam M., Haynes B., Hahn B.H., and Korber B. Consensus and ancestral state HIV vaccines-Reply to Nickle et al. Science 299 5612 (2003) 1515-1518
11. Gao F., Korber B.T., Weaver E., Liao H.X., Hahn B.H., and Haynes B.F. Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity. Expert Rev. Vaccines 3 Suppl. 4 (2004) S161-S168
12. Gao F., Weaver E.A., Lu Z., Li Y., Liao H.X., Ma B., Alam S.M., Scearce R.M., Sutherland L.L., Yu J.S., Decker J.M., Shaw G.M., Montefiori D.C., Korber B.T., Hahn B.H., and Haynes B.F. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. J. Virol. 79 2 (2005) 1154-1163
13. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., and Korber B. Diversity considerations in HIV-1 vaccine selection. Science 296 5577 (2002) 2354-2360
14. Goulder P.J., Altfeld M.A., Rosenberg E.S., Nguyen T., Tang Y., Eldridge R.L., Addo M.M., He S., Mukherjee J.S., Phillips M.N., Bunce M., Kalams S.A., Sekaly R.P., Walker B.D., and Brander C. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193 2 (2001) 181-194
15. Herbeck J.T., Nickle D.C., Learn G.H., Gottlieb G.S., Curlin M.E., Heath L., and Mullins J.I. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J. Virol. 80 4 (2006) 1637-1644
16. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
17. Huang X.L., Fan Z., Zheng L., Borowski L., Li H., Thomas E.K., Hildebrand W.H., Zhao X.Q., and Rinaldo C.R. Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins. J. Infect. Dis. 187 2 (2003) 315-319
18. Jensen M.A., Li F.S., van 't Wout A.B., Nickle D.C., Shriner D., He H.X., McLaughlin S., Shankarappa R., Margolick J.B., and Mullins J.I. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 77 24 (2003) 13376-13388
19. Kaslow R.A., Ostrow D.G., Detels R., Phair J.P., Polk B.F., and Rinaldo Jr. C.R. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126 2 (1987) 310-318
20. Kaufmann D.E., Bailey P.M., Sidney J., Wagner B., Norris P.J., Johnston M.N., Cosimi L.A., Addo M.M., Lichterfeld M., Altfeld M., Frahm N., Brander C., Sette A., Walker B.D., and Rosenberg E.S. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78 9 (2004) 4463-4477
21. Kelleher A.D., Long C., Holmes E.C., Allen R.L., Wilson J., Conlon C., Workman C., Shaunak S., Olson K., Goulder P., Brander C., Ogg G., Sullivan J.S., Dyer W., Jones I.I., McMichael A.J., Rowland-Jones S., and Phillips R.E. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193 3 (2001) 375-386
22. In: Korber B.T., Brander C., Haynes B.F., Koup R.A., Moore J.P., Walker B.D., and Watkins D.I. (Eds). HIV Immunology and HIV/SIV Vaccine Database (2003), Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico, Los Alamos, NM 87545 LA-UR 04-8162
23. Korber B., Frahm N., Yusim K., Fischer W., Walker B., and Brander C. T-cell Vaccine and Peptide Reagent Design Based on Restricted Patterns of Variation in Conserved HIV Proteins. AIDS Vaccine 2005 (2005) Abstract #61, Montreal, Canda
24. Kumar S., Tamura K., Jakobsen I.K., and Nei M. MEGA2: molecular Evolutionary genetics analysis software for microcomputers. Bioinformatics 17 12 (2001) 1244-1245
25. Learn G.H., and Mullins J.I. The use of an inferred epidemic ancestral sequence as a vaccine immunogen. 7the Annual International Discussion Meeting on HIV Dynamics and Evolution, Seattle, WA (2000)
26. Learn G., and Mullins J.I. The microbial forensic use of HIV sequences. In: Leitner T., Foley B., Hahn B., Marx P., McCutchan F., Mellors J., Wolinsky S., and Korber B. (Eds). Theoretical Biology and Biophysics Group. HIV Sequence Compendium 2003 (2003), Los Alamos National Laboratory LA-UR number 04-7420
27. Learn G.H., Muthui D., Brodie S.J., Zhu T., Diem K., Mullins J.I., and Corey L. Virus population Homogenization following acute human immunodeficiency virus type 1 infection. J. Virol. 76 23 (2002) 11953-11959
28. Liu Y., Zhao H., Genowati I., McNevin J., Nickle D., Shriner D., Wong K., Cao J., Davies K., Rose L., McElrath M.J., and Mullins J.I. CTL Responses as Major Selective Forces Shaping the Course of HIV-1 Evolution in vivo. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA (2004)
29. Mansky L.M., and Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69 8 (1995) 5087-5094
30. Mullins J.I., Nickle D.C., Heath L., Rodrigo A.G., and Learn G.H. Immunogen sequence: the fourth tier of AIDS vaccine design. Expert Rev. Vaccines 3 Suppl. 1 (2004) S151-S159
31. Myers G., Korber B., Wain-Hobson S., Smith R.F., and Pavlakis G.N. Human retroviruses and AIDS, 1993. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (1993), Los Alamos National Laboratory
32. Nickle D.C., Jensen M.A., Gottlieb G.S., Shriner D., Learn G.H., Rodrigo A.G., and Mullins J.I. Consensus and ancestral state HIV vaccines. Science 299 5612 (2003) 1515-1518 (author 2003a)
33. Nickle D.C., Jensen M.A., Shriner D., Brodie S.J., Frenkel L.M., Mittler J.E., and Mullins J.I. Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J. Virol. 77 9 (2003) 5540-5546
34. Nickle D.C., Shriner D., Mittler J.E., Frenkel L.M., and Mullins J.I. Importance and detection of virus reservoirs and compartments of HIV infection. Curr. Opin. Microbiol. 6 4 (2003) 410-416
35. Nielsen R., and Yang Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148 3 (1998) 929-936
36. Novitsky V., Smith U.R., Gilbert P., McLane M.F., Chigwedere P., Williamson C., Ndung'u T., Klein I., Chang S.Y., Peter T., Thior I., Foley B.T., Gaolekwe S., Rybak N., Gaseitsiwe S., Vannberg F., Marlink R., Lee T.H., and Essex M. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?. J. Virol. 76 11 (2002) 5435-5451
37. O'Connor D.H., Allen T.M., Vogel T.U., Jing P., DeSouza I.P., Dodds E., Dunphy E.J., Melsaether C., Mothe B., Yamamoto H., Horton H., Wilson N., Hughes A.L., and Watkins D.I. Acute phase cytotoxic T lymphocyte escape is a hallmark of Simian immunodeficiency virus infection. Nat. Med. 8 5 (2002) 493-499
38. Pathak V.K., and Temin H.M. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. U.S.A. 87 16 (1990) 6024-6028
39. Pathak V.K., and Temin H.M. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. U.S.A. 87 16 (1990) 6019-6023
40. Poss M., Rodrigo A.G., Gosink J.J., Learn G.H., de Vange Panteleeff D., Martin Jr. H.L., Bwayo J., Kreiss J.K., and Overbaugh J. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J. Virol. 72 10 (1998) 8240-8251
41. Rinaldo Jr. C.R., Gupta P., Huang X., Fan Z., Mullins J.I., Gange S., Farzadegan H., Shankarappa R., Muñoz A., and Margolick J.B. Anti-HIV-1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in the progression of HIV-1 infection. AIDS Res. Hum. Retrovir. 14 16 (1998) 1423-1433
42. Roberts J.D., Bebenek K., and Kunkel T.A. The accuracy of reverse transcriptase from HIV-1. Science 242 4882 (1988) 1171-1173
43. Ross H.A., and Rodrigo A.G. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J. Virol. 76 22 (2002) 11715-11720
44. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., and Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73 12 (1999) 10489-10502
45. Shriner D., Shankarappa R., Jensen M.A., Nickle D.C., Mittler J.E., Margolick J.B., and Mullins J.I. Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection. Genetics 166 3 (2004) 1155-1164
46. Swofford, D.L., 2002. PAUP* 4.0: Phylogenetic Analysis Using Parsimony (And other methods). ver 4.0b10. 2002.
47. van 't Wout A.B., Kootstra N.A., Mulder-Kampinga G.A., Albrecht-van Lent N., Scherpbier H.J., Veenstra J., Boer K., Coutinho R.A., Miedema F., and Schuitemaker H. Macrophage-tropic variants initiate HIV-1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94 5 (1994) 2060-2067
48. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., Saag M.S., and Shaw G.M. Viral dynamics of HIV-1 infection. Nature 373 6510 (1995) 117-122
49. Williamson S. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol. Biol. Evol. 20 8 (2003) 1318-1325
50. Wolfs T.F., Zwart G., Bakker M., and Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189 (1992) 103-110
51. Wolinsky S.M., Wike C.M., Korber B.T.M., Hutto C., Parks W.P., Rosenblum L.L., Kunstman K.J., Furtado M.R., and Muñoz J.L. Selective transmission of HIV-1 variants from mother to infants. Science 255 (1992) 1134-1137
52. Wolinsky S.M., Korber B.T.M., Neumann A.U., Daniels M., Kuntsman K.J., Whetsell A.J., Furtado M.R., Cao Y., Ho D.D., Safrit J.T., and Koup R.A. Adaptive evolution of HIV-1 during the natural course of infection. Science 272 (1996) 537-542
53. Yamaguchi-Kabata Y., and Gojobori T. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J. Virol. 74 9 (2000) 4335-4350
54. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13 5 (1997) 555-556
55. Yu X.G., Addo M.M., Rosenberg E.S., Rodriguez W.R., Lee P.K., Fitzpatrick C.A., Johnston M.N., Strick D., Goulder P.J., Walker B.D., and Altfeld M. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J. Virol. 76 17 (2002) 8690-8701
56. Yusim K., Kesmir C., Gaschen B., Addo M.M., Altfeld M., Brunak S., Chigaev A., Detours V., and Korber B.T. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J. Virol. 76 17 (2002) 8757-8768
57. Zanotto P.M., Kallas E.G., de Souza R.F., and Holmes E.C. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153 3 (1999) 1077-1089
58. Zhang L.Q., MacKenzie P., Cleland A., Holmes E.C., Leigh Brown A.J., and Simmonds P. Selection for specific sequences in the external envelope protein of HIV-1 upon primary infection. J. Virol. 67 6 (1993) 3345-3356
59. Zhao X.Q., Huang X.L., Gupta P., Borowski L., Fan Z., Watkins S.C., Thomas E.K., and Rinaldo C.R. Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells. J. Virol. 76 6 (2002) 3007-3014
60. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., and Ho D.D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261 (1993) 1179-1181
61. Zhu T., Wang N., Carr A., Nam D.S., Moor-Jankowski R., Cooper D.A., and Ho D.D. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70 5 (1996) 3098-3107